Anti Hair Loss Medicine Market

Home Healthcare And Pharmaceutical Anti Hair Loss Medicine Market

Anti-Hair Loss Medicine Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Product, Medicine); By Gender (Male, Female); By End User (Dermatology Clinics, Hospitals, Home Care Setting); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published Date: May 2023
Report ID: BWC23363
Available Format: PDF
Page: 400

Report Overview

Increasing prevalence of hair loss among the global population, growing availability of a wide range of hair loss treatments and products, and a spurring demand for personalized hair loss treatment solutions are projected to propel the expansion of the global anti-hair loss medicine market during the forecast period between 2023 and 2029.

Global Anti-Hair Loss Medicine Market - Industry Trends & Forecast Report, 2029

Global anti-hair loss medicine market size was estimated at USD 24.41 billion in 2022. During the forecast period between 2023 and 2029, the size of global anti-hair loss medicine market is projected to grow at a CAGR of 4.48% reaching a value of USD 32.93 billion by 2029. Major growth drivers for global anti-hair loss medicine market include increasing prevalence of hair loss or alopecia among the global population, growing aging population, changing lifestyles, and increasing awareness and acceptance of hair loss treatments. Alopecia can be caused by a range of factors, including genetics, hormonal imbalances, stress, and medical conditions, among others. As a result, there is a significant demand for effective treatments and solutions to help prevent or reverse hair loss. In recent years, there has been a growing trend towards the use of natural and herbal remedies for hair loss, such as herbal oils, shampoos, and supplements. Technological advancements have led to the development of innovative hair loss solutions, such as laser caps and helmets, scalp micropigmentation, and platelet-rich plasma therapy. Also, rising disposable incomes and the desire for improved aesthetics have led to greater demand for hair restoration products.

Global Anti-Hair Loss Medicine Market

Global Anti-Hair Loss Medicine Market – Overview

The anti-hair loss medicine market refers to the industry that involves the development, manufacturing, and marketing of pharmaceuticals and other treatments designed to prevent or reduce hair loss or alopecia. Hair loss has become a significant concern for many individuals in today's world due to various internal factors such as hormonal imbalances, major illnesses, aging, and others. The market for hair loss treatment products is growing rapidly as there is a rising demand for treatments for androgenetic alopecia, a hair problem that affects women, men, and children, leading to baldness and requiring medication. For instance, the American Academy of Dermatology reports that more than 40% of women globally experience hair loss issues by age 40 due to hormonal imbalances and other reasons. Additionally, increasing stress levels resulting from the ever-changing lifestyles have contributed significantly to the prevalence of hair loss. As the demand for hair loss treatment products continues to rise globally, manufacturers are introducing new and innovative products to address this concern. By targeting conscious consumers and revitalizing their product portfolios, manufacturers are aiming to attain a larger market share. As a result, the global anti-hair loss medicine market is expected to experience significant growth in the coming years.

Global Anti-Hair Loss Medicine Market

Growth Drivers

Increasing Prevalence of Hair Loss

The market for hair loss prevention products is being driven by the growing prevalence of hair loss among young individuals. According to the Mayo Foundation for Medical Education and Research (MFMER), hair loss can be caused by a variety of factors, including hereditary makeup that accelerates with aging, hormonal changes due to pregnancy, childbirth, menopause, and thyroid problems, side effects of certain medications and treatments, exposure to radiation during treatment or other conditions, stressful lifestyles causing hair thinning, and the use of chemical sprays during excessive hairstyling. To combat hair loss, people are continuously seeking effective hair care products, such as shampoos and conditioners, oils, and serums, to reduce hair loss and restore hair growth. The National Institute of Health (NIH) reports that long-term stress in the US can put people at risk of various health problems, including depression and anxiety, as well as digestion and sleep-related issues. The US Census data and Simmons National Consumer Survey (NHCS-2010 to 2020) estimated that consumers in the US spent approximately USD 65 on hair care products per year, and more than 12.4 million Americans had used hair regrowth products in 2020.

Restraints

Limited Efficacy of Some Hair Loss Medicines

The limited efficacy of certain hair loss medicines is anticipated to restrain the growth of the global anti-hair loss medicine market. While there are several effective hair loss treatment products available, some may not produce the desired results for all individuals. It can lead to dissatisfaction among users, causing them to search for alternative products or treatments. Additionally, some hair loss medicines may have side effects, which can deter individuals from using them. This can result in decreased demand for these products and a slowdown in the growth of the global anti-hair loss medicine market.

Impact of COVID-19 on Global Anti-Hair Loss Medicine Market

COVID-19 pandemic adversely affected the global anti-hair loss medicine market. The pandemic disrupted supply chains and caused significant economic slowdowns, leading to a decrease in demand for non-essential products, including hair loss treatment products. Lockdowns and social distancing measures also impacted the availability of hair loss treatment services, such as hair transplant surgeries and in-clinic treatments, which led to a shift towards home-based treatments and products. However, the pandemic also led to increased stress levels, which can exacerbate hair loss. It drove the demand for hair loss treatment products, particularly those that can be used at home.

Global Anti-Hair Loss Medicine Market

Segmental Coverage

Global Anti-Hair Loss Medicine Market – By Type

Based on type, the global anti-hair loss medicine market is bifurcated into Product and Medicine segments. The product segment holds a higher share in the global anti-hair loss medicine market. The product segment includes shampoo & conditioner, oil, and serum. Among them, the shampoo conditioner segment holds the highest market share, while the oils segment is expected to record the highest compound annual growth rate (CAGR) during the forecast period. The popularity of shampoos and conditioners is due to their widespread use, and the unisex segment was the most widely used. On the other hand, the men's segment is expected to have the highest CAGR during the forecast period, primarily driven by the increasing demand for hair loss prevention products among young men. While most manufacturers offer a range of unisex hair care products, such as shampoos, conditioners, oils, and serums, they are now revitalizing their product portfolios to target specific customers by introducing new products at affordable prices to gain a larger market share.

Anti-Hair Loss Medicine Market

Global Anti-Hair Loss Medicine Market – By Gender

Based on gender, global anti-hair loss medicine market is divided into Male and Female segments. The male segment is expected to hold a higher market share during the forecast period, due to an increasing demand for hair loss prevention products among men, particularly among the younger generation. Additionally, many manufacturers in the market are providing unisex hair care products like shampoos, conditioners, oils, and serums. However, these manufacturers are currently updating their product portfolios to cater to specific customers by introducing new products at reasonable prices to capture a larger market share.

Global Anti-Hair Loss Medicine Market – By End User

Based on end user, the global anti-hair loss medicine market is segmented into Dermatology Clinics, Hospitals, and Home Care Setting. In 2022, the dermatology clinics segment held the highest market share, while the homecare settings segment is expected to grow during the forecast period. Hair loss is a common and significant issue that often leads to psychological distress and symptoms of depression. Whether temporary or long-lasting, severe hair loss has been driving the growth of the dermatology clinics segment in the market for hair loss treatment products, and this trend is expected to continue during the forecast period.

Anti-Hair Loss Medicine Market Size

Global Anti-Hair Loss Medicine Market – By Region

The in-depth research report on the global anti-hair loss medicine market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). The APAC region holds the highest share in the global anti-hair loss medicine market due to the presence of a large population suffering from hair loss issues, which has led to increased demand for hair loss treatment products in the region. The rising disposable income, increasing awareness about hair loss prevention and treatment, and the availability of a wide range of hair care products in the market have also contributed to the growth of the anti-hair loss medicine market in the APAC region. Also, the growth of e-commerce and online retail platforms has made it easier for consumers to access hair loss treatment products, further boosting the market growth.

Competitive Landscape

Major players operating in global anti-hair loss medicine market include Merck & Co., Inc., Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Sun Pharmaceutical Industries Ltd., Histogen Inc., Concert Pharmaceuticals, Inc., Aclaris Therapeutics, Inc., Follicum AB, Polichem S.A., Cassiopea SpA, PureTech Health, Kythera Biopharmaceuticals, Inc., Kerastem Technologies, and HairClone. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

In November 2022 – Unilever, a global major consumer products company, announced the recall of its aerosol dry shampoo brands, including Dove. Those shampoo products were discovered that they had been contaminated with benzene that may cause cancer. The US FDA recall also covered brands including Nexxus, Suave, Tresemmé and Tigi.
In June 2022 - Eli Lilly and Company and Incyte announced that the US FDA granted marketing approval for Oluminant (baricitinib), a once-daily pill, as a first-in-disease systemic treatment for adults with severe alopecia areata (AA). AA is a disease that happens when the immune system attacks hair follicles and causes hair loss. Oluminant is available as 4-mg, 2-mg and 1-mg tablets.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast Period – 2023–2029
Facts Covered	Revenue in USD Billion
Market Coverage	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Product/ Service Segmentation	Type, Gender, End Users, Region
Key Players	Merck & Co., Inc., Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Sun Pharmaceutical Industries Ltd., Histogen Inc., Concert Pharmaceuticals, Inc., Aclaris Therapeutics, Inc., Follicum AB, Polichem S.A., Cassiopea SpA, PureTech Health, Kythera Biopharmaceuticals, Inc., Kerastem Technologies, HairClone

By Type

Product
Medicine

By Gender

Male
Female

By End Users

Dermatology Clinic
Hospitals
Home Care Setting

By Region

North America
Europe
Asia Pacific (APAC)
Latin America
Middle East and Africa (MEA)

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global Anti-Hair Loss Medicine Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Increasing prevalence of hair loss among the global population
    2. Availability of a wide range of hair loss treatments and products
    3. Rising demand for personalized hair loss treatment solutions
  2. Restraints
    1. Limited efficacy of some hair loss medicines
    2. Social stigma associated with hair loss leading to a reluctance to seek treatment
  3. Opportunities
    1. Expansion of distribution channels and availability of hair loss medicines in emerging markets
    2. Increasing adoption of combination therapies for hair loss treatment
  4. Challenges
    1. Limited understanding of the underlying causes of hair loss
3. Product Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Anti-Hair Loss Medicine Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share and Forecast
  1. By Type
    1. Product
      1. shampoo & conditioner
      2. oil
      3. serum
      4. others
    2. Medicine
  2. By Gender
    1. Male
    2. Female
  3. By End Users
    1. Dermatology Clinic
    2. Hospitals
    3. Home Care Setting
    4. Others
  4. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America Anti-Hair Loss Medicine Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Gender
  3. By End Users
  4. By Country
    1. United States
      1. By Type
      2. By Gender
      3. By End Users
    2. Canada
      1. By Type
      2. By Gender
      3. By End Users
Europe Anti-Hair Loss Medicine Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Gender
  3. By End Users
  4. By Country
    1. Germany
      1. By Type
      2. By Gender
      3. By End Users
    2. United Kingdom
      1. By Type
      2. By Gender
      3. By End Users
    3. Italy
      1. By Type
      2. By Gender
      3. By End Users
    4. France
      1. By Type
      2. By Gender
      3. By End Users
    5. Spain
      1. By Type
      2. By Gender
      3. By End Users
    6. Belgium
      1. By Type
      2. By Gender
      3. By End Users
    7. Russia
      1. By Type
      2. By Gender
      3. By End Users
    8. The Netherlands
      1. By Type
      2. By Gender
      3. By End Users
    9. Rest of Europe
      1. By Type
      2. By Gender
      3. By End Users
Asia-Pacific Anti-Hair Loss Medicine Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Gender
  3. By End Users
  4. By Country
    1. China
      1. By Type
      2. By Gender
      3. By End Users
    2. India
      1. By Type
      2. By Gender
      3. By End Users
    3. Japan
      1. By Type
      2. By Gender
      3. By End Users
    4. South Korea
      1. By Type
      2. By Gender
      3. By End Users
    5. Australia & New Zealand
      1. By Type
      2. By Gender
      3. By End Users
    6. Indonesia
      1. By Type
      2. By Gender
      3. By End Users
    7. Malaysia
      1. By Type
      2. By Gender
      3. By End Users
    8. Singapore
      1. By Type
      2. By Gender
      3. By End Users
    9. Vietnam
      1. By Type
      2. By Gender
      3. By End Users
    10. Rest of APAC
      1. By Type
      2. By Gender
      3. By End Users
Latin America Anti-Hair Loss Medicine Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Gender
  3. By End Users
  4. By Country
    1. Brazil
      1. By Type
      2. By Gender
      3. By End Users
    2. Mexico
      1. By Type
      2. By Gender
      3. By End Users
    3. Argentina
      1. By Type
      2. By Gender
      3. By End Users
    4. Peru
      1. By Type
      2. By Gender
      3. By End Users
    5. Rest of LATAM
      1. By Type
      2. By Gender
      3. By End Users
Middle East & Africa Anti-Hair Loss Medicine Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Gender
  3. By End Users
  4. By Country
    1. Saudi Arabia
      1. By Type
      2. By Gender
      3. By End Users
    2. UAE
      1. By Type
      2. By Gender
      3. By End Users
    3. Qatar
      1. By Type
      2. By Gender
      3. By End Users
    4. Kuwait
      1. By Type
      2. By Gender
      3. By End Users
    5. South Africa
      1. By Type
      2. By Gender
      3. By End Users
    6. Nigeria
      1. By Type
      2. By Gender
      3. By End Users
    7. Algeria
      1. By Type
      2. By Gender
      3. By End Users
    8. Rest of MEA
      1. By Type
      2. By Gender
      3. By End Users
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Anti-Hair Loss Medicine Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Covid-19 on Global Anti-Hair Loss Medicine Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. Merck & Co., Inc.
2. Johnson & Johnson
3. Dr. Reddy’s Laboratories Ltd.
4. Cipla Inc.
5. Sun Pharmaceutical Industries Ltd.
6. Histogen Inc.
7. Concert Pharmaceuticals, Inc.
8. Aclaris Therapeutics, Inc.
9. Follicum AB
10. Polichem S.A.
11. Cassiopea SpA
12. PureTech Health
13. Kythera Biopharmaceuticals, Inc.
14. Kerastem Technologies
15. HairClone
16. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1 Global Anti-Hair Loss Medicine Market Segmentation

Figure 2 Global Anti-Hair Loss Medicine Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Global Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 5 Global Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 6 Global Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 7 Global Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 8 Global Anti-Hair Loss Medicine Market Share, By Region, By Value, 2019–2029

Figure 9 North America Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 10 North America Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 11 North America Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 12 North America Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 13 North America Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 14 United States Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 15 United States Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 16 United States Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 17 United States Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 18 Canada Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 19 Canada Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 20 Canada Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 21 Canada Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 22 Europe Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 23 Europe Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 24 Europe Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 25 Europe Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 26 Europe Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 27 Germany Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 28 Germany Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 29 Germany Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 30 Germany Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 31 United Kingdom Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 32 United Kingdom Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 33 United Kingdom Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 34 United Kingdom Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 35 Italy Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 36 Italy Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 37 Italy Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 38 Italy Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 39 France Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 40 France Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 41 France Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 42 France Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 43 Spain Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 44 Spain Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 45 Spain Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 46 Spain Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 47 Belgium Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 48 Belgium Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 49 Belgium Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 50 Belgium Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 51 Russia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 52 Russia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 53 Russia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 54 Russia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 55 The Netherlands Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 56 The Netherlands Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 57 The Netherlands Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 58 The Netherlands Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 59 Rest of Europe Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 60 Rest of Europe Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 61 Rest of Europe Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 62 Rest of Europe Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 63 Asia-Pacific Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 64 Asia-Pacific Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 65 Asia-Pacific Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 66 Asia-Pacific Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 67 Asia-Pacific Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 68 China Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 69 China Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 70 China Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 71 China Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 72 India Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 73 India Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 74 India Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 75 India Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 76 Japan Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 77 Japan Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 78 Japan Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 79 Japan Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 80 South Korea Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 81 South Korea Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 82 South Korea Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 83 South Korea Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 84 Australia & New Zealand Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 85 Australia & New Zealand Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 86 Australia & New Zealand Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 87 Australia & New Zealand Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 88 Indonesia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 89 Indonesia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 90 Indonesia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 91 Indonesia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 92 Malaysia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 93 Malaysia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 94 Malaysia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 95 Malaysia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 96 Singapore Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 97 Singapore Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 98 Singapore Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 99 Singapore Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 100 Vietnam Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 101 Vietnam Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 102 Vietnam Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 103 Vietnam Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 104 Rest of APAC Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 105 Rest of APAC Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 106 Rest of APAC Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 107 Rest of APAC Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 108 Latin America Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 109 Latin America Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 110 Latin America Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 111 Latin America Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 112 Latin America Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 113 Brazil Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 114 Brazil Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 115 Brazil Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 116 Brazil Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 117 Mexico Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 118 Mexico Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 119 Mexico Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 120 Mexico Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 121 Argentina Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 122 Argentina Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 123 Argentina Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 124 Argentina Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 125 Peru Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 126 Peru Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 127 Peru Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 128 Peru Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 129 Rest of LATAM Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 130 Rest of LATAM Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 131 Rest of LATAM Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 132 Rest of LATAM Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 133 Middle East & Africa Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 134 Middle East & Africa Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 135 Middle East & Africa Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 136 Middle East & Africa Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 137 Middle East & Africa Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 138 Saudi Arabia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 139 Saudi Arabia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 140 Saudi Arabia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 141 Saudi Arabia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 142 UAE Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 143 UAE Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 144 UAE Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 145 UAE Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 146 Qatar Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 147 Qatar Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 148 Qatar Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 149 Qatar Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 150 Kuwait Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 151 Kuwait Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 152 Kuwait Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 153 Kuwait Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 154 South Africa Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 155 South Africa Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 156 South Africa Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 157 South Africa Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 158 Nigeria Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 159 Nigeria Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 160 Nigeria Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 161 Nigeria Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 162 Algeria Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 163 Algeria Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 164 Algeria Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 165 Algeria Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 166 Rest of MEA Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 167 Rest of MEA Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 168 Rest of MEA Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 169 Rest of MEA Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

List of Tables

Table 1 Global Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 2 Global Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 3 Global Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 4 Global Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 5 Global Anti-Hair Loss Medicine Market Share, By Region, By Value, 2019–2029

Table 6 North America Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 7 North America Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 8 North America Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 9 North America Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 10 North America Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 11 United States Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 12 United States Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 13 United States Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 14 United States Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 15 Canada Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 16 Canada Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 17 Canada Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 18 Canada Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 19 Europe Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 20 Europe Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 21 Europe Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 22 Europe Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 23 Europe Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 24 Germany Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 25 Germany Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 26 Germany Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 27 Germany Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 28 United Kingdom Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 29 United Kingdom Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 30 United Kingdom Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 31 United Kingdom Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 32 Italy Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 33 Italy Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 34 Italy Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 35 Italy Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 36 France Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 37 France Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 38 France Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 39 France Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 40 Spain Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 41 Spain Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 42 Spain Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 43 Spain Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 44 Belgium Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 45 Belgium Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 46 Belgium Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 47 Belgium Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 48 Russia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 49 Russia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 50 Russia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 51 Russia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 52 The Netherlands Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 53 The Netherlands Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 54 The Netherlands Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 55 The Netherlands Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 56 Rest of Europe Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 57 Rest of Europe Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 58 Rest of Europe Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 59 Rest of Europe Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 60 Asia-Pacific Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 61 Asia-Pacific Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 62 Asia-Pacific Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 63 Asia-Pacific Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 64 Asia-Pacific Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 65 China Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 66 China Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 67 China Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 68 China Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 69 India Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 70 India Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 71 India Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 72 India Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 73 Japan Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 74 Japan Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 75 Japan Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 76 Japan Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 77 South Korea Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 78 South Korea Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 79 South Korea Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 80 South Korea Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 81 Australia & New Zealand Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 82 Australia & New Zealand Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 83 Australia & New Zealand Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 84 Australia & New Zealand Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 85 Indonesia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 86 Indonesia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 87 Indonesia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 88 Indonesia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 89 Malaysia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 90 Malaysia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 91 Malaysia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 92 Malaysia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 93 Singapore Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 94 Singapore Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 95 Singapore Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 96 Singapore Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 97 Vietnam Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 98 Vietnam Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 99 Vietnam Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 100 Vietnam Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 101 Rest of APAC Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 102 Rest of APAC Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 103 Rest of APAC Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 104 Rest of APAC Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 105 Latin America Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 106 Latin America Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 107 Latin America Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 108 Latin America Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 109 Latin America Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 110 Brazil Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 111 Brazil Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 112 Brazil Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 113 Brazil Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 114 Mexico Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 115 Mexico Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 116 Mexico Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 117 Mexico Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 118 Argentina Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 119 Argentina Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 120 Argentina Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 121 Argentina Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 122 Peru Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 123 Peru Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 124 Peru Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 125 Peru Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 126 Rest of LATAM Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 127 Rest of LATAM Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 128 Rest of LATAM Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 129 Rest of LATAM Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 130 Middle East & Africa Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 131 Middle East & Africa Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 132 Middle East & Africa Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 133 Middle East & Africa Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 134 Middle East & Africa Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 135 Saudi Arabia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 136 Saudi Arabia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 137 Saudi Arabia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 138 Saudi Arabia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 139 UAE Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 140 UAE Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 141 UAE Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 142 UAE Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 143 Qatar Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 144 Qatar Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 145 Qatar Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 146 Qatar Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 147 Kuwait Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 148 Kuwait Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 149 Kuwait Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 150 Kuwait Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 151 South Africa Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 152 South Africa Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 153 South Africa Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 154 South Africa Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 155 Nigeria Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 156 Nigeria Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 157 Nigeria Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 158 Nigeria Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 159 Algeria Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 160 Algeria Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 161 Algeria Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 162 Algeria Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 163 Rest of MEA Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 164 Rest of MEA Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 165 Rest of MEA Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 166 Rest of MEA Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 167 Merck & Co., Inc. Company Overview

Table 168 Merck & Co., Inc. Financial Overview

Table 169 Johnson & Johnson Company Overview

Table 170 Johnson & Johnson Financial Overview

Table 171 Dr. Reddy’s Laboratories Ltd. Company Overview

Table 172 Dr. Reddy’s Laboratories Ltd. Financial Overview

Table 173 Cipla Inc. Company Overview

Table 174 Cipla Inc. Financial Overview

Table 175 Sun Pharmaceutical Industries Ltd. Company Overview

Table 176 Sun Pharmaceutical Industries Ltd. Financial Overview

Table 177 Histogen Inc. Company Overview

Table 178 Histogen Inc. Financial Overview

Table 179 Concert Pharmaceuticals, Inc. Company Overview

Table 180 Concert Pharmaceuticals, Inc. Financial Overview

Table 181 Aclaris Therapeutics, Inc. Company Overview

Table 182 Aclaris Therapeutics, Inc. Financial Overview

Table 183 Follicum AB Company Overview

Table 184 Follicum AB Financial Overview

Table 185 Polichem S.A. Company Overview

Table 186 Polichem S.A. Financial Overview

Table 187 Cassiopea SpA Company Overview

Table 188 Cassiopea SpA Financial Overview

Table 189 PureTech Health Company Overview

Table 190 PureTech Health Financial Overview

Table 191 Kythera Biopharmaceuticals, Inc. Company Overview

Table 192 Kythera Biopharmaceuticals, Inc. Financial Overview

Table 193 Kerastem Technologies Company Overview

Table 194 Kerastem Technologies Financial Overview

Table 195 HairClone Company Overview

Table 196 HairClone Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What are the major factors driving the growth of Global Anti-Hair Loss Medicine Market?

Ans: Major factors driving the growth of Global Anti-Hair Loss Medicine Market include increasing prevalence of hair loss among the global population, growing availability of a wide range of hair loss treatments and products, and rising demand for personalized hair loss treatment solutions.

2. What is the current market size of Global Anti-Hair Loss Medicine Market?

Ans: Global Anti-Hair Loss Medicine Market size was estimated at USD 24.41 billion in 2022.

3. Which is the leading segment in the Global Anti-Hair Loss Medicine Market by type?

Ans: The product segment is expected to hold a higher market share in the Global Anti-Hair Loss Medicine Market by type.

4. Which segment accounts for a major market share in the Global Anti-Hair Loss Medicine Market by gender?

Ans: The male segment is expected to hold a higher market share in the Global Anti-Hair Loss Medicine Market by gender.

5. Name the key players in Global Anti-Hair Loss Medicine Market.

Ans: Key players in Global Anti-Hair Loss Medicine Market include Merck & Co., Inc., Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Sun Pharmaceutical Industries Ltd., Histogen Inc., Concert Pharmaceuticals, Inc., Aclaris Therapeutics, Inc., Follicum AB, Polichem S.A., Cassiopea SpA, PureTech Health, Kythera Biopharmaceuticals, Inc., Kerastem Technologies, and HairClone.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4850
GROUP LICENSE
$ 5750
ENTERPRISE LICENSE
$ 8150
EXCEL DATA PACK
$ 3250

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.